checkAd

    Medigene AG  273  0 Kommentare Medigene participates at upcoming conferences

    Business news for the stock market

    Martinsried/Munich (pta010/30.07.2019/07:30) - Medigene AG (FSE: MDG1, Prime Standard) today announced its participation at the following upcoming investor conferences:

    Trout European Biotech Investor Day
    Date: 1 August 2019
    Location: New York, USA

    BTIG Biotech Conference
    Date: 12 August 2019
    Location: New York, USA

    Citi's Annual Biotech Conference
    Date: 04 - 05 September 2019
    Location: Boston, USA

    Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. The company is developing highly innovative immunotherapies to target various forms and stages of cancer. Medigene concentrates on the development of personalized T cell-based therapies, with associated projects currently in pre-clinical and clinical development.
    For more information, please visit http://www.medigene.com

    This press release contains forward-looking statements representing the opinion of Medigene as of the date of this release. The actual results achieved by Medigene may differ significantly from the forward-looking statements made herein. Medigene is not bound to update any of these forward-looking statements. Medigene is a registered trademark of Medigene AG. This trademark may be owned or licensed in select locations only.

    Lesen Sie auch

    Contact Medigene AG
    Julia Hofmann, Dr. Robert Mayer
    Tel.: +49 - 89 - 20 00 33 - 33 01,
    email: investor@medigene.com

    In case you no longer wish to receive any information about Medigene, please inform us by e-mail (investor@medigene.com). We will then delete your address from our distribution list.

    (end)

    emitter: Medigene AG
    address: Lochhamer Straße 11, 82152 Planegg
    country: Germany
    contact person: Medigene PR/IR
    phone: +49 89 2000 33 3301
    e-mail: investor@medigene.com
    website: www.medigene.de

    ISIN(s): DE000A1X3W00 (share)
    stock exchanges: regulated market in Frankfurt; free market in Stuttgart, free market in Munich, free market in Hamburg, free market in Dusseldorf, free market in Hannover; open market in Berlin, Tradegate

    [ source: http://www.pressetext.com/news/20190730010 ]



    Diskutieren Sie über die enthaltenen Werte



    Verfasst von Pressetext (Adhoc)
    Medigene AG Medigene participates at upcoming conferences Medigene AG (FSE: MDG1, Prime Standard) today announced its participation at the following upcoming investor conferences: Trout European Biotech Investor Day Date: 1 August 2019 Location: …

    Schreibe Deinen Kommentar

    Disclaimer